Centurion Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$538K Buy
1,384
+10
+0.7% +$3.99K 0.13% 142
2026
Q2
$531K Sell
1,374
-25
-2% -$9.27K 0.13% 150
2026
Q1
$410K Buy
1,399
+10
+0.7% +$3.29K 0.09% 194
2025
Q4
$487K Buy
1,389
+37
+3% +$12.5K 0.11% 165
2025
Q3
$437K Buy
+1,352
New +$420K 0.1% 172

Other funds holding ELV

Centurion Wealth Management's ELV Position: Q3 2026 in Review

Centurion Wealth Management increased its Elevance Health (ELV) stake by 0.73% in Q3 2026, buying an estimated $3.99K and bringing the position to 1,384 shares worth $538K. The position accounts for 0.13% of the portfolio, ranked #142.

Centurion Wealth Management first reported a position in ELV in Q3 2025 and has held it in 5 quarters since. 866 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Centurion Wealth Management held 1,384 shares of Elevance Health worth $538K as of Q3 2026.
  • Centurion Wealth Management bought 10 Elevance Health shares in Q3 2026, an estimated $3.99K.
  • Elevance Health made up 0.13% of Centurion Wealth Management's portfolio in Q3 2026, its #142 holding.
  • Centurion Wealth Management first reported a position in Elevance Health in Q3 2025 and has held it in 5 quarters since.
  • 866 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.